{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T05:44:32Z","timestamp":1788241472649,"version":"build-2803163510"},"reference-count":90,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2012,3,1]],"date-time":"2012-03-01T00:00:00Z","timestamp":1330560000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["La Presse M\u00e9dicale"],"published-print":{"date-parts":[[2012,3]]},"DOI":"10.1016\/j.lpm.2011.10.024","type":"journal-article","created":{"date-parts":[[2012,1,28]],"date-time":"2012-01-28T17:53:26Z","timestamp":1327773206000},"page":"e163-e176","source":"Crossref","is-referenced-by-count":54,"special_numbering":"P2","title":["Current management and therapeutical perspectives in thrombotic thrombocytopenic purpura"],"prefix":"10.1016","volume":"41","author":[{"given":"Paul","family":"Coppo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Agn\u00e8s","family":"Veyradier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"22","key":"10.1016\/j.lpm.2011.10.024_bib0005","doi-asserted-by":"crossref","first-page":"1578","DOI":"10.1056\/NEJM199811263392202","article-title":"von Willebrand factor-cleaving protease in thrombotic thrombocytopenic purpura and the hemolytic-uremic syndrome","volume":"339","author":"Furlan","year":"1998","journal-title":"N Engl J Med"},{"issue":"22","key":"10.1016\/j.lpm.2011.10.024_bib0010","doi-asserted-by":"crossref","first-page":"1585","DOI":"10.1056\/NEJM199811263392203","article-title":"Antibodies to von Willebrand factor-cleaving protease in acute thrombotic thrombocytopenic purpura","volume":"339","author":"Tsai","year":"1998","journal-title":"N Engl J Med"},{"issue":"12","key":"10.1016\/j.lpm.2011.10.024_bib0015","doi-asserted-by":"crossref","first-page":"2005","DOI":"10.1182\/blood-2010-04-280479","article-title":"Thrombotic thrombocytopenic purpura directly linked with ADAMTS13 inhibition in the baboon (Papio ursinus)","volume":"116","author":"Feys","year":"2011","journal-title":"Blood"},{"issue":"4","key":"10.1016\/j.lpm.2011.10.024_bib0020","doi-asserted-by":"crossref","first-page":"856","DOI":"10.1111\/j.1538-7836.2010.03772.x","article-title":"HLA-DRB1*11: a strong risk factor for acquired severe ADAMTS13 deficiency-related idiopathic thrombotic thrombocytopenic purpura in Caucasians","volume":"8","author":"Coppo","year":"2010","journal-title":"J Thromb Haemost"},{"issue":"6855","key":"10.1016\/j.lpm.2011.10.024_bib0025","doi-asserted-by":"crossref","first-page":"488","DOI":"10.1038\/35097008","article-title":"Mutations in a member of the ADAMTS gene family cause thrombotic thrombocytopenic purpura","volume":"413","author":"Levy","year":"2001","journal-title":"Nature"},{"issue":"10","key":"10.1016\/j.lpm.2011.10.024_bib0030","doi-asserted-by":"crossref","first-page":"2752","DOI":"10.1172\/JCI26007","article-title":"Shigatoxin triggers thrombotic thrombocytopenic purpura in genetically susceptible ADAMTS13-deficient mice","volume":"115","author":"Motto","year":"2005","journal-title":"J Clin Invest"},{"issue":"23","key":"10.1016\/j.lpm.2011.10.024_bib0035","doi-asserted-by":"crossref","first-page":"1432","DOI":"10.1056\/NEJM198212023072306","article-title":"Unusually large plasma factor VIII: von Willebrand factor multimers in chronic relapsing thrombotic thrombocytopenic purpura","volume":"307","author":"Moake","year":"1982","journal-title":"N Engl J Med"},{"issue":"6","key":"10.1016\/j.lpm.2011.10.024_bib0040","doi-asserted-by":"crossref","first-page":"1456","DOI":"10.1172\/JCI112736","article-title":"Involvement of large plasma von Willebrand factor (vWF) multimers and unusually large vWF forms derived from endothelial cells in shear stress-induced platelet aggregation","volume":"78","author":"Moake","year":"1986","journal-title":"J Clin Invest"},{"issue":"6","key":"10.1016\/j.lpm.2011.10.024_bib0045","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1097\/00005792-198111000-00003","article-title":"Thrombotic thrombocytopenic purpura. Report of 25 cases and review of the literature","volume":"60","author":"Ridolfi","year":"1981","journal-title":"Medicine (Baltimore)"},{"issue":"4","key":"10.1016\/j.lpm.2011.10.024_bib0050","doi-asserted-by":"crossref","first-page":"e10208","DOI":"10.1371\/journal.pone.0010208","article-title":"Predictive features of severe acquired ADAMTS13 deficiency in idiopathic thrombotic microangiopathies: the French TMA reference center experience","volume":"5","author":"Coppo","year":"2010","journal-title":"PLoS One"},{"issue":"8","key":"10.1016\/j.lpm.2011.10.024_bib0055","doi-asserted-by":"crossref","first-page":"1500","DOI":"10.1182\/blood-2009-09-243790","article-title":"Survival and relapse in patients with thrombotic thrombocytopenic purpura","volume":"115","author":"Hovinga","year":"2010","journal-title":"Blood"},{"issue":"8","key":"10.1016\/j.lpm.2011.10.024_bib0060","doi-asserted-by":"crossref","first-page":"1654","DOI":"10.1111\/j.1537-2995.2010.02653.x","article-title":"The utility of patient characteristics in predicting severe ADAMTS13 deficiency and response to plasma exchange","volume":"50","author":"Bentley","year":"2010","journal-title":"Transfusion"},{"issue":"2","key":"10.1016\/j.lpm.2011.10.024_bib0065","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1111\/j.1537-2995.2004.00626.x","article-title":"Severe deficiency of VWF-cleaving protease (ADAMTS13) activity defines a distinct population of thrombotic microangiopathy patients","volume":"44","author":"Raife","year":"2004","journal-title":"Transfusion"},{"issue":"6","key":"10.1016\/j.lpm.2011.10.024_bib0070","doi-asserted-by":"crossref","first-page":"1549","DOI":"10.1093\/ndt\/gfl127","article-title":"Acute myocardial infarction in thrombotic microangiopathies--clinical characteristics, risk factors and outcome","volume":"21","author":"Patschan","year":"2006","journal-title":"Nephrol Dial Transplant"},{"issue":"2","key":"10.1016\/j.lpm.2011.10.024_bib0075","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1111\/j.1537-2995.2007.01534.x","article-title":"Clinical cardiac involvement in thrombotic thrombocytopenic purpura: a systematic review","volume":"48","author":"Hawkins","year":"2008","journal-title":"Transfusion"},{"issue":"4","key":"10.1016\/j.lpm.2011.10.024_bib0080","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1111\/j.1538-7836.2009.03285.x","article-title":"Cardiac involvement in acute thrombotic thrombocytopenic purpura: association with troponin T and IgG antibodies to ADAMTS 13","volume":"7","author":"Hughes","year":"2009","journal-title":"J Thromb Haemost"},{"issue":"7","key":"10.1016\/j.lpm.2011.10.024_bib0085","doi-asserted-by":"crossref","first-page":"834","DOI":"10.5858\/2003-127-834-TTPAHU","article-title":"Thrombotic thrombocytopenic purpura and hemolytic uremic syndrome are distinct pathologic entities. A review of 56 autopsy cases","volume":"127","author":"Hosler","year":"2003","journal-title":"Arch Pathol Lab Med"},{"issue":"3","key":"10.1016\/j.lpm.2011.10.024_bib0090","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1016\/j.autrev.2007.11.009","article-title":"Microvascular and microangiopathic antiphospholipid-associated syndromes (\u201cMAPS\u201d): semantic or antisemantic?","volume":"7","author":"Asherson","year":"2008","journal-title":"Autoimmun Rev"},{"issue":"5","key":"10.1016\/j.lpm.2011.10.024_bib0095","doi-asserted-by":"crossref","first-page":"1845","DOI":"10.1182\/blood-2002-08-2399","article-title":"von Willebrand factor cleaving protease and ADAMTS13 mutations in childhood TTP","volume":"101","author":"Schneppenheim","year":"2003","journal-title":"Blood"},{"issue":"6","key":"10.1016\/j.lpm.2011.10.024_bib0100","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1056\/NEJM199108083250604","article-title":"Comparison of plasma exchange with plasma infusion in the treatment of thrombotic thrombocytopenic purpura. Canadian Apheresis Study Group","volume":"325","author":"Rock","year":"1991","journal-title":"N Engl J Med"},{"issue":"1","key":"10.1016\/j.lpm.2011.10.024_bib0105","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1097\/00005792-200301000-00003","article-title":"High-dose plasma infusion versus plasma exchange as early treatment of thrombotic thrombocytopenic purpura\/hemolytic-uremic syndrome","volume":"82","author":"Coppo","year":"2003","journal-title":"Medicine (Baltimore)"},{"issue":"1","key":"10.1016\/j.lpm.2011.10.024_bib0110","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1007\/s00134-004-2505-0","article-title":"Outcome of severe adult thrombotic microangiopathies in the intensive care unit","volume":"31","author":"Pene","year":"2005","journal-title":"Intensive Care Med"},{"issue":"2","key":"10.1016\/j.lpm.2011.10.024_bib0115","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1046\/j.1365-2141.1996.d01-1800.x","article-title":"Cryosupernatant as replacement fluid for plasma exchange in thrombotic thrombocytopenic purpura. Members of the Canadian Apheresis Group","volume":"94","author":"Rock","year":"1996","journal-title":"Br J Haematol"},{"issue":"Suppl.\u00a01","key":"10.1016\/j.lpm.2011.10.024_bib0120","first-page":"707a","article-title":"Cryopoor plasma does not improve early response in primary adult thrombotic thrombocytopenic purpura (TTP)","volume":"92","author":"Zeigler","year":"1998","journal-title":"Blood"},{"issue":"6","key":"10.1016\/j.lpm.2011.10.024_bib0125","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1056\/NEJM199108083250605","article-title":"Improved survival in thrombotic thrombocytopenic purpura-hemolytic uremic syndrome. Clinical experience in 108 patients","volume":"325","author":"Bell","year":"1991","journal-title":"N Engl J Med"},{"issue":"6","key":"10.1016\/j.lpm.2011.10.024_bib0130","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1007\/s00277-009-0877-5","article-title":"High versus standard dose methylprednisolone in the acute phase of idiopathic thrombotic thrombocytopenic purpura: a randomized study","volume":"89","author":"Balduini","year":"2010","journal-title":"Ann Hematol"},{"issue":"5","key":"10.1016\/j.lpm.2011.10.024_bib0135","doi-asserted-by":"crossref","first-page":"1148","DOI":"10.1111\/j.1538-7836.2006.01879.x","article-title":"The role of pulse dexamethasone in acquired idiopathic thrombotic thrombocytopenic purpura","volume":"4","author":"Rojnuckarin","year":"2006","journal-title":"J Thromb Haemost"},{"issue":"1","key":"10.1016\/j.lpm.2011.10.024_bib0140","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1002\/ajh.2830410119","article-title":"Successful treatment of thrombotic thrombocytopenic purpura with high-dose corticosteroid","volume":"41","author":"Toyoshige","year":"1992","journal-title":"Am J Hematol"},{"issue":"4","key":"10.1016\/j.lpm.2011.10.024_bib0145","first-page":"429","article-title":"Antiplatelet agents in thrombotic thrombocytopenic purpura (TTP). Results of a randomized multicenter trial by the Italian Cooperative Group for TTP","volume":"82","author":"Bobbio-Pallavicini","year":"1997","journal-title":"Haematologica"},{"issue":"1","key":"10.1016\/j.lpm.2011.10.024_bib0150","doi-asserted-by":"crossref","first-page":"27","DOI":"10.7326\/0003-4819-96-1-27","article-title":"Ineffectiveness of aspirin and dipyridamole in the treatment of thrombotic thrombocytopenic purpura","volume":"96","author":"Rosove","year":"1982","journal-title":"Ann Intern Med"},{"issue":"17","key":"10.1016\/j.lpm.2011.10.024_bib0155","doi-asserted-by":"crossref","first-page":"1931","DOI":"10.1001\/jama.1981.03320170043028","article-title":"Hazard of platelet transfusion in thrombotic thrombocytopenic purpura","volume":"246","author":"Harkness","year":"1981","journal-title":"JAMA"},{"issue":"3","key":"10.1016\/j.lpm.2011.10.024_bib0160","first-page":"194","article-title":"Deleterious effects of platelet transfusions and recovery thrombocytosis in patients with thrombotic microangiopathy","volume":"24","author":"Gordon","year":"1987","journal-title":"Semin Hematol"},{"issue":"10","key":"10.1016\/j.lpm.2011.10.024_bib0165","doi-asserted-by":"crossref","first-page":"1384","DOI":"10.1046\/j.1537-2995.2002.00260.x","article-title":"Platelet transfusion and thrombotic thrombocytopenic purpura","volume":"42","author":"de la Rubia","year":"2002","journal-title":"Transfusion"},{"issue":"1","key":"10.1016\/j.lpm.2011.10.024_bib0170","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1007\/s12098-010-0224-9","article-title":"Case of TTP with cerebral infarct secondary to platelet transfusion","volume":"78","author":"Tripathi","year":"2011","journal-title":"Indian J Pediatr"},{"issue":"3","key":"10.1016\/j.lpm.2011.10.024_bib0175","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1002\/ajh.1179","article-title":"Effectiveness of platelet transfusions after plasma exchange in adult thrombotic thrombocytopenic purpura: a report of two cases","volume":"68","author":"Coppo","year":"2001","journal-title":"Am J Hematol"},{"issue":"5","key":"10.1016\/j.lpm.2011.10.024_bib0180","doi-asserted-by":"crossref","first-page":"873","DOI":"10.1111\/j.1537-2995.2008.02082.x","article-title":"Clinical outcomes after platelet transfusions in patients with thrombotic thrombocytopenic purpura","volume":"49","author":"Swisher","year":"2009","journal-title":"Transfusion"},{"issue":"6","key":"10.1016\/j.lpm.2011.10.024_bib0185","doi-asserted-by":"crossref","first-page":"1405","DOI":"10.1111\/j.1538-7836.2006.01960.x","article-title":"Patterns of changes of anti-ADAMTS13 after plasma exchange","volume":"4","author":"Mannucci","year":"2006","journal-title":"J Thromb Haemost"},{"issue":"3","key":"10.1016\/j.lpm.2011.10.024_bib0190","first-page":"203","article-title":"Rituximab for managing relapsing or refractory patients with idiopathic thrombotic thrombocytopenic purpura--haemolytic uraemic syndrome","volume":"8","author":"Caramazza","year":"2010","journal-title":"Blood Transfus"},{"issue":"7","key":"10.1016\/j.lpm.2011.10.024_bib0195","doi-asserted-by":"crossref","first-page":"1746","DOI":"10.1182\/blood-2011-03-341131","article-title":"A phase II study of the safety and efficacy of rituximab with plasma exchange in acute acquired thrombotic thrombocytopenic purpura","volume":"118","author":"Scully","year":"2011","journal-title":"Blood"},{"issue":"1","key":"10.1016\/j.lpm.2011.10.024_bib0455","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1097\/CCM.0b013e31822e9d66","article-title":"First-line rituximab efficacy and safety in patients with acquired idiopathic thrombotic thrombocytopenic purpura experiencing a suboptimal response to therapeutical plasma exchange: results of a prospective multicenter phase 2 study","volume":"40","author":"Froissart","year":"2012","journal-title":"Crit Care Med"},{"issue":"4","key":"10.1016\/j.lpm.2011.10.024_bib0205","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1111\/j.1600-0609.1994.tb00649.x","article-title":"Vincristine sulfate for the treatment of thrombotic thrombocytopenic purpura refractory to plasma-exchange. The Italian Cooperative Group for TTP","volume":"52","author":"Bobbio-Pallavicini","year":"1994","journal-title":"Eur J Haematol"},{"issue":"1","key":"10.1016\/j.lpm.2011.10.024_bib0210","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1002\/ajh.2830350105","article-title":"Rapid improvement of thrombotic thrombocytopenic purpura with vincristine and plasmapheresis","volume":"35","author":"Welborn","year":"1990","journal-title":"Am J Hematol"},{"issue":"1","key":"10.1016\/j.lpm.2011.10.024_bib0215","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1111\/j.1537-2995.2005.03146.x","article-title":"Combination vincristine and plasma exchange as initial therapy in patients with thrombotic thrombocytopenic purpura: one institution's experience and review of the literature","volume":"45","author":"Ziman","year":"2005","journal-title":"Transfusion"},{"issue":"4","key":"10.1016\/j.lpm.2011.10.024_bib0220","doi-asserted-by":"crossref","first-page":"791","DOI":"10.1001\/archinte.1992.00400160089017","article-title":"Response to plasma exchange and splenectomy in thrombotic thrombocytopenic purpura. A 10-year experience at a single institution","volume":"152","author":"Onundarson","year":"1992","journal-title":"Arch Intern Med"},{"issue":"5","key":"10.1016\/j.lpm.2011.10.024_bib0225","doi-asserted-by":"crossref","first-page":"768","DOI":"10.1111\/j.1365-2141.2005.05681.x","article-title":"Splenectomy for the treatment of thrombotic thrombocytopenic purpura","volume":"130","author":"Kappers-Klunne","year":"2005","journal-title":"Br J Haematol"},{"issue":"2","key":"10.1016\/j.lpm.2011.10.024_bib0230","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1159\/000188439","article-title":"A case of thrombotic thrombocytopenic purpura successfully treated with cyclophosphamide","volume":"69","author":"Zieschang","year":"1995","journal-title":"Nephron"},{"issue":"4","key":"10.1016\/j.lpm.2011.10.024_bib0235","first-page":"325","article-title":"Treatment of thrombotic thrombocytopenic purpura with high-dose immunoglobulins. Results in 17 patients. Italian Cooperative Group for TTP","volume":"80","author":"Centurioni","year":"1995","journal-title":"Haematologica"},{"issue":"3","key":"10.1016\/j.lpm.2011.10.024_bib0240","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1046\/j.1365-2141.1998.00602.x","article-title":"Successful use of cyclosporine A in the treatment of refractory thrombotic thrombocytopenic purpura","volume":"100","author":"Hand","year":"1998","journal-title":"Br J Haematol"},{"issue":"3","key":"10.1016\/j.lpm.2011.10.024_bib0245","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1007\/BF02982800","article-title":"Late response to cyclosporine in refractory thrombotic thrombocytopenic purpura","volume":"76","author":"Nosari","year":"2002","journal-title":"Int J Hematol"},{"issue":"1","key":"10.1016\/j.lpm.2011.10.024_bib0250","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1046\/j.0141-9854.2003.00573.x","article-title":"Excellent response of refractory life-threatening thrombotic thrombocytopenic purpura to cyclosporine treatment","volume":"26","author":"Itala","year":"2004","journal-title":"Clin Lab Haematol"},{"issue":"5","key":"10.1016\/j.lpm.2011.10.024_bib0255","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1111\/j.1600-0609.2007.00832.x","article-title":"Mycophenolate mofetil in a case of relapsed, refractory thrombotic thrombocytopenic purpura","volume":"78","author":"Ahmad","year":"2007","journal-title":"Eur J Haematol"},{"issue":"3","key":"10.1016\/j.lpm.2011.10.024_bib0260","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1111\/j.1365-2141.2007.06819.x","article-title":"Cyclosporin and plasma exchange in thrombotic thrombocytopenic purpura: long-term follow-up with serial analysis of ADAMTS13 activity","volume":"139","author":"Cataland","year":"2007","journal-title":"Br J Haematol"},{"issue":"12","key":"10.1016\/j.lpm.2011.10.024_bib0265","doi-asserted-by":"crossref","first-page":"911","DOI":"10.1002\/ajh.21281","article-title":"Effect of prophylactic cyclosporine therapy on ADAMTS13 biomarkers in patients with idiopathic thrombotic thrombocytopenic purpura","volume":"83","author":"Cataland","year":"2008","journal-title":"Am J Hematol"},{"issue":"2","key":"10.1016\/j.lpm.2011.10.024_bib0270","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1111\/j.1537-2995.2007.01530.x","article-title":"Twice-daily plasma exchange for patients with refractory thrombotic thrombocytopenic purpura: the experience of the Oklahoma Registry, 1989 through 2006","volume":"48","author":"Nguyen","year":"2008","journal-title":"Transfusion"},{"issue":"7","key":"10.1016\/j.lpm.2011.10.024_bib0275","doi-asserted-by":"crossref","first-page":"2815","DOI":"10.1182\/blood-2006-02-006064","article-title":"Prognostic value of anti-ADAMTS 13 antibody features (Ig isotype, titer, and inhibitory effect) in a cohort of 35 adult French patients undergoing a first episode of thrombotic microangiopathy with undetectable ADAMTS 13 activity","volume":"109","author":"Ferrari","year":"2007","journal-title":"Blood"},{"issue":"2","key":"10.1016\/j.lpm.2011.10.024_bib0280","doi-asserted-by":"crossref","first-page":"232","DOI":"10.3324\/haematol.11739","article-title":"ADAMTS13 and anti-ADAMTS13 antibodies as markers for recurrence of acquired thrombotic thrombocytopenic purpura during remission","volume":"93","author":"Peyvandi","year":"2008","journal-title":"Haematologica"},{"issue":"5","key":"10.1016\/j.lpm.2011.10.024_bib0285","doi-asserted-by":"crossref","first-page":"488","DOI":"10.1111\/j.1365-2141.2010.08385.x","article-title":"Different clinical severity of first episodes and recurrences of thrombotic thrombocytopenic purpura","volume":"151","author":"Lotta","year":"2010","journal-title":"Br J Haematol"},{"issue":"5","key":"10.1016\/j.lpm.2011.10.024_bib0290","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1007\/BF01784041","article-title":"The role of splenectomy in the treatment of relapsing thrombotic thrombocytopenic purpura","volume":"70","author":"Veltman","year":"1995","journal-title":"Ann Hematol"},{"issue":"3","key":"10.1016\/j.lpm.2011.10.024_bib0295","first-page":"320","article-title":"Splenectomy in relapsing and plasma-refractory acquired thrombotic thrombocytopenic purpura","volume":"89","author":"Kremer Hovinga","year":"2004","journal-title":"Haematologica"},{"issue":"1","key":"10.1016\/j.lpm.2011.10.024_bib0300","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1002\/ajh.2830200110","article-title":"Therapy of chronic relapsing thrombotic thrombocytopenic purpura with prednisone and azathioprine","volume":"20","author":"Moake","year":"1985","journal-title":"Am J Hematol"},{"issue":"1","key":"10.1016\/j.lpm.2011.10.024_bib0305","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1002\/(SICI)1096-8652(199801)57:1<57::AID-AJH10>3.0.CO;2-6","article-title":"Chronic relapsing thrombotic thrombocytopenic purpura: role of therapy with cyclosporine","volume":"57","author":"Pasquale","year":"1998","journal-title":"Am J Hematol"},{"issue":"8","key":"10.1016\/j.lpm.2011.10.024_bib0310","first-page":"844","article-title":"Frequently relapsing thrombotic thrombocytopenic purpura treated with cytotoxic immunosuppressive therapy","volume":"86","author":"Allan","year":"2001","journal-title":"Haematologica"},{"issue":"5","key":"10.1016\/j.lpm.2011.10.024_bib0315","doi-asserted-by":"crossref","first-page":"742","DOI":"10.1111\/j.1365-2141.2008.07515.x","article-title":"Pregnancy-induced thrombocytopenia and TTP, and the risk of fetal death, in Upshaw-Schulman syndrome: a series of 15 pregnancies in 9 genotyped patients","volume":"144","author":"Fujimura","year":"2009","journal-title":"Br J Haematol"},{"issue":"9","key":"10.1016\/j.lpm.2011.10.024_bib0320","doi-asserted-by":"crossref","first-page":"1931","DOI":"10.1111\/j.1538-7836.2006.02098.x","article-title":"Novel ADAMTS-13 mutations in an adult with delayed onset thrombotic thrombocytopenic purpura","volume":"4","author":"Tao","year":"2006","journal-title":"J Thromb Haemost"},{"issue":"2","key":"10.1016\/j.lpm.2011.10.024_bib0325","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1111\/j.1538-7836.2008.02846.x","article-title":"Prevalence of the ADAMTS-13 missense mutation R1060W in late onset adult thrombotic thrombocytopenic purpura","volume":"6","author":"Camilleri","year":"2008","journal-title":"J Thromb Haemost"},{"issue":"3","key":"10.1016\/j.lpm.2011.10.024_bib0330","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1111\/j.1365-3083.2008.02143.x","article-title":"Human immunodeficiency virus-associated thrombotic microangiopathies: clinical characteristics and outcome according to ADAMTS13 activity","volume":"68","author":"Malak","year":"2008","journal-title":"Scand J Immunol"},{"issue":"9","key":"10.1016\/j.lpm.2011.10.024_bib0335","doi-asserted-by":"crossref","first-page":"1710","DOI":"10.1111\/j.1537-2995.2007.01346.x","article-title":"ADAMTS13 activity and the presence of acquired inhibitors in human immunodeficiency virus-related thrombotic thrombocytopenic purpura","volume":"47","author":"Gunther","year":"2007","journal-title":"Transfusion"},{"issue":"3","key":"10.1016\/j.lpm.2011.10.024_bib0340","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1111\/j.1365-2141.2004.05325.x","article-title":"Thrombotic thrombocytopenic purpura in patients with retroviral infection is highly responsive to plasma infusion therapy","volume":"128","author":"Novitzky","year":"2005","journal-title":"Br J Haematol"},{"issue":"4","key":"10.1016\/j.lpm.2011.10.024_bib0345","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1111\/j.1365-2141.2011.08636.x","article-title":"Human immunodeficiency virus associated thrombotic thrombocytopenic purpura--favourable outcome with plasma exchange and prompt initiation of highly active antiretroviral therapy","volume":"153","author":"Hart","year":"2011","journal-title":"Br J Haematol"},{"issue":"1","key":"10.1016\/j.lpm.2011.10.024_bib0350","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1634\/theoncologist.12-1-11","article-title":"Disseminated malignancy misdiagnosed as thrombotic thrombocytopenic purpura: a report of 10 patients and a systematic review of published cases","volume":"12","author":"Francis","year":"2007","journal-title":"Oncologist"},{"issue":"8","key":"10.1016\/j.lpm.2011.10.024_bib0355","doi-asserted-by":"crossref","first-page":"769","DOI":"10.1634\/theoncologist.2009-0067","article-title":"Cancer awareness in atypical thrombotic microangiopathies","volume":"14","author":"Oberic","year":"2009","journal-title":"Oncologist"},{"key":"10.1016\/j.lpm.2011.10.024_bib0360","doi-asserted-by":"crossref","first-page":"S20","DOI":"10.1038\/ki.2008.613","article-title":"Ticlopidine- and clopidogrel-associated thrombotic thrombocytopenic purpura (TTP): review of clinical, laboratory, epidemiological, and pharmacovigilance findings (1989\u20132008)","volume":"112","author":"Zakarija","year":"2009","journal-title":"Kidney Int Suppl"},{"issue":"6","key":"10.1016\/j.lpm.2011.10.024_bib0365","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1097\/01.mbc.0000240918.65306.20","article-title":"Successful management of pregnancy in women with a history of thrombotic thrombocytopaenic purpura","volume":"17","author":"Scully","year":"2006","journal-title":"Blood Coagul Fibrinolysis"},{"issue":"4","key":"10.1016\/j.lpm.2011.10.024_bib0370","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1097\/00043426-200304000-00016","article-title":"Case series of thrombotic thrombocytopenic purpura in children and adolescents","volume":"25","author":"Horton","year":"2003","journal-title":"J Pediatr Hematol Oncol"},{"issue":"3","key":"10.1016\/j.lpm.2011.10.024_bib0375","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1067\/mpd.2003.79","article-title":"Severe deficiency of the specific von Willebrand factor-cleaving protease (ADAMTS 13) activity in a subgroup of children with atypical hemolytic uremic syndrome","volume":"142","author":"Veyradier","year":"2003","journal-title":"J Pediatr"},{"issue":"1","key":"10.1016\/j.lpm.2011.10.024_bib0380","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1053\/j.seminhematol.2003.10.009","article-title":"The Japanese experience with thrombotic thrombocytopenic purpura-hemolytic uremic syndrome","volume":"41","author":"Matsumoto","year":"2004","journal-title":"Semin Hematol"},{"issue":"2","key":"10.1016\/j.lpm.2011.10.024_bib0385","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1097\/MPH.0b013e3181cbd265","article-title":"Difficulties in diagnosing congenital thrombotic thrombocytopenic purpura","volume":"32","author":"Klukowska","year":"2010","journal-title":"J Pediatr Hematol Oncol"},{"issue":"4","key":"10.1016\/j.lpm.2011.10.024_bib0390","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1002\/pbc.22094","article-title":"Thrombotic thrombocytopenic purpura in childhood","volume":"53","author":"Bouw","year":"2009","journal-title":"Pediatr Blood Cancer"},{"issue":"2","key":"10.1016\/j.lpm.2011.10.024_bib0395","doi-asserted-by":"crossref","first-page":"166","DOI":"10.3324\/haematol.2008.002493","article-title":"Inherited thrombotic thrombocytopenic purpura","volume":"94","author":"Galbusera","year":"2009","journal-title":"Haematologica"},{"issue":"1","key":"10.1016\/j.lpm.2011.10.024_bib0400","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1007\/s00467-008-0863-5","article-title":"Thrombotic thrombocytopenic purpura related to severe ADAMTS13 deficiency in children","volume":"24","author":"Loirat","year":"2009","journal-title":"Pediatr Nephrol"},{"issue":"9","key":"10.1016\/j.lpm.2011.10.024_bib0405","doi-asserted-by":"crossref","first-page":"1749","DOI":"10.1007\/s00467-009-1186-x","article-title":"Rituximab therapy in two children with autoimmune thrombotic thrombocytopenic purpura","volume":"24","author":"Albaramki","year":"2009","journal-title":"Pediatr Nephrol"},{"issue":"1","key":"10.1016\/j.lpm.2011.10.024_bib0410","doi-asserted-by":"crossref","first-page":"53","DOI":"10.3109\/08880010903401752","article-title":"A 9-month-old infant with acquired idiopathic thrombotic thrombocytopenic purpura caused by inhibitory IgG-autoantibody to ADAMTS13","volume":"27","author":"Sato","year":"2010","journal-title":"Pediatr Hematol Oncol"},{"issue":"1","key":"10.1016\/j.lpm.2011.10.024_bib0415","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1053\/j.seminhematol.2003.10.007","article-title":"Severe ADAMTS-13 deficiency in childhood","volume":"41","author":"Schneppenheim","year":"2004","journal-title":"Semin Hematol"},{"issue":"3","key":"10.1016\/j.lpm.2011.10.024_bib0420","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1002\/pbc.21818","article-title":"Transient TTP in childhood","volume":"52","author":"Moskowitz","year":"2009","journal-title":"Pediatr Blood Cancer"},{"issue":"3","key":"10.1016\/j.lpm.2011.10.024_bib0425","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1097\/MBC.0b013e32833679cb","article-title":"Acquired, noncongenital thrombotic thrombocytopenic purpura in children and adolescents: clinical management and the use of ADAMTS 13 assays","volume":"21","author":"McDonald","year":"2010","journal-title":"Blood Coagul Fibrinolysis"},{"issue":"2","key":"10.1016\/j.lpm.2011.10.024_bib0430","doi-asserted-by":"crossref","first-page":"e90","DOI":"10.1097\/PCC.0b013e3181e89f8f","article-title":"Successful treatment with rituximab for acute refractory thrombotic thrombocytopenic purpura related to acquired ADAMTS13 deficiency: a pediatric report and literature review","volume":"12","author":"Harambat","year":"2011","journal-title":"Pediatr Crit Care Med"},{"issue":"5","key":"10.1016\/j.lpm.2011.10.024_bib0435","doi-asserted-by":"crossref","first-page":"522","DOI":"10.1055\/s-0030-1255446","article-title":"Preclinical testing of human recombinant von Willebrand factor: ADAMTS13 cleavage capacity in animals as criterion for species suitability","volume":"36","author":"Muchitsch","year":"2010","journal-title":"Semin Thromb Hemost"},{"issue":"5","key":"10.1016\/j.lpm.2011.10.024_bib0440","doi-asserted-by":"crossref","first-page":"936","DOI":"10.1111\/j.1538-7836.2011.04224.x","article-title":"Recombinant ADAMTS13 normalizes von Willebrand factor-cleaving activity in plasma of acquired TTP patients by overriding inhibitory antibodies","volume":"9","author":"Plaimauer","year":"2011","journal-title":"J Thromb Haemost"},{"issue":"3","key":"10.1016\/j.lpm.2011.10.024_bib0445","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1160\/TH10-08-0520","article-title":"Inhibition of von Willebrand factor by ARC1779 in patients with acute thrombotic thrombocytopenic purpura","volume":"105","author":"Jilma-Stohlawetz","year":"2011","journal-title":"Thromb Haemost"},{"issue":"2","key":"10.1016\/j.lpm.2011.10.024_bib0450","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1172\/JCI41062","article-title":"N-acetylcysteine reduces the size and activity of von Willebrand factor in human plasma and mice","volume":"121","author":"Chen","year":"2011","journal-title":"J Clin Invest"}],"container-title":["La Presse M\u00e9dicale"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0755498211006348?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0755498211006348?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,4,18]],"date-time":"2024-04-18T15:49:06Z","timestamp":1713455346000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0755498211006348"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,3]]},"references-count":90,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2012,3]]}},"alternative-id":["S0755498211006348"],"URL":"https:\/\/doi.org\/10.1016\/j.lpm.2011.10.024","relation":{},"ISSN":["0755-4982"],"issn-type":[{"value":"0755-4982","type":"print"}],"subject":[],"published":{"date-parts":[[2012,3]]}}}